EGFR FISH versus mutation : Different tests, different end-pointsCAPPUZZO, Federico.Lung cancer. 2008, Vol 60, Num 2, pp 160-165, issn 0169-5002, 6 p.Article

Impact of biomarkers on non-small cell lung cancer treatment : Special focus: Response prediction: Coordinated by E. Van Cutsem and F. CiardielloTOSCHI, Luca; CAPPUZZO, Federico.Targeted oncology. 2010, Vol 5, Num 1, pp 5-17, issn 1776-2596, 13 p.Article

Prognostic and Predictive Value of K-RAS Mutations in Non-Small Cell Lung CancerCALIFANO, Raffaele; LANDI, Lorenza; CAPPUZZO, Federico et al.Drugs (Basel). 2012, Vol 72, pp 28-36, issn 0012-6667, 9 p., SUP1Article

Protein kinase inhibitors to treat non-small-cell lung cancerMINUTI, Gabriele; D'INCECCO, Armida; LANDI, Lorenza et al.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 9, pp 1203-1213, issn 1465-6566, 11 p.Article

Present and future treatment of advanced non-small cell lung cancerCRINO, Lucio; CAPPUZZO, Federico.Seminars in oncology. 2002, Vol 29, Num 3, pp 9-16, issn 0093-7754, SUP9Article

Multimodality therapy for non-small cell lung cancer (NSCLC): ongoing Italian experiences in the adjuvant and neoadjuvant settingsCRINO, Lucio; CAPPUZZO, Federico.Lung cancer. 2001, Vol 34, pp S45-S47, issn 0169-5002, SUP3Conference Paper

Prospective Molecular Marker Analyses of EGFR and KRAS From a Randomized, Placebo-Controlled Study of Erlotinib Maintenance Therapy in Advanced Non-Small-Cell Lung CancerBRUGGER, Wolfram; TRILLER, Nadja; TRUNZER, Kerstin et al.Journal of clinical oncology. 2011, Vol 29, Num 31, pp 4113-4120, issn 0732-183X, 8 p.Article

Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: An italian lung cancer project observational studyCAPPUZZO, Federico; SELVAGGI, Giovanni; DE ANGELIS, Verena et al.Cancer. 2003, Vol 98, Num 1, pp 128-134, issn 0008-543X, 7 p.Article

Maintenance treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic OncologyGRIDELLI, Cesare; DE MARINIS, Filippo; PIRKER, Robert et al.Lung cancer. 2012, Vol 76, Num 3, pp 269-279, issn 0169-5002, 11 p.Article

Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancerDZIADZIUSZKO, Rafal; WITTA, Samir E; VARELLA-GARCIA, Marileila et al.Clinical cancer research. 2006, Vol 12, Num 10, pp 3078-3084, issn 1078-0432, 7 p.Article

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung CancerSOLOMON, Benjamin J; MOK, Tony; IYER, Shrividya et al.The New England journal of medicine. 2014, Vol 371, Num 23, pp 2167-2177, issn 0028-4793, 11 p.Article

Gefitinib Versus Vinorelbine in Chemotherapy-Naive Elderly Patients With Advanced Non-Small-Cell Lung Cancer (INVITE) : A Randomized, Phase II StudyCRINO, Lucio; CAPPUZZO, Federico; DUFFIELD, Emma L et al.Journal of clinical oncology. 2008, Vol 26, Num 26, pp 4253-4260, issn 0732-183X, 8 p.Article

Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-akt-positive or never smoker patients with advanced non-small-cell lung cancer: The ONCOBELL trialCAPPUZZO, Federico; LIGORIO, Claudia; BARTOLINI, Stefania et al.Journal of clinical oncology. 2007, Vol 25, Num 16, pp 2248-2255, issn 0732-183X, 8 p.Article

Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patientsCAPPUZZO, Federico; VARELLA-GARCIA, Marileila; FRANKLIN, Wilbur A et al.Journal of clinical oncology. 2005, Vol 23, Num 22, pp 5007-5018, issn 0732-183X, 12 p.Article

Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancerCAPPUZZO, Federico; MAGRINI, Elisabetta; SPREAFICO, Anna et al.Journal of the National Cancer Institute. 2004, Vol 96, Num 15, pp 1133-1141, issn 0027-8874, 9 p.Article

Identifying and Targeting ROS1 Gene Fusions in Non―Small Cell Lung CancerDAVIES, Kurtis D; LE, Anh T; ALLOISIO, Marco et al.Clinical cancer research (Print). 2012, Vol 18, Num 17, pp 4570-4579, issn 1078-0432, 10 p.Article

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancerPEIFER, Martin; FERNANDEZ-CUESTA, Lynnette; MENON, Roopika et al.Nature genetics. 2012, Vol 44, Num 10, pp 1104-1110, issn 1061-4036, 7 p.Article

Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring studySARTORE-BIANCHI, Andrea; FIEUWS, Stiffen; SKOKAN, Margaret et al.Journal of clinical pathology. 2012, Vol 65, Num 3, pp 220-225, issn 0021-9746, 6 p.Article

Genetic Activation of the MET Pathway and Prognosis of Patients With High-Risk, Radically Resected Gastric CancerGRAZIANO, Francesco; GALLUCCIO, Nadia; RULLI, Eliana et al.Journal of clinical oncology. 2011, Vol 29, Num 36, pp 4789-4795, issn 0732-183X, 7 p.Article

Gemcitabine and Vinorelbine in Pemetrexed-Pretreated Patients With Malignant Pleural MesotheliomaZUCALI, Paolo A; CERESOLI, Giovanni L; GARASSINO, Isabella et al.Cancer. 2008, Vol 112, Num 7, pp 1555-1561, issn 0008-543X, 7 p.Article

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signalingENGELMAN, Jeffrey A; ZEJNULLAHU, Kreshnik; KOSAKA, Takayuki et al.Science (Washington, D.C.). 2007, Vol 316, Num 5827, pp 1039-1043, issn 0036-8075, 5 p.Article

Anaplastic Lymphoma Kinase Gene Rearrangements in Cytological Samples of Non-Small Cell Lung Cancer: Comparison With Histological AssessmentPROIETTI, Agnese; ALI, Greta; MICCOLI, Mario et al.Cancer cytopathology. 2014, Vol 122, Num 6, pp 445-453, issn 1934-662X, 9 p.Article

Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: Re-analysis of the SATURN studyMAZIERES, Julien; BRUGGER, Wolfram; CAPPUZZO, Federico et al.Lung cancer. 2013, Vol 82, Num 2, pp 231-237, issn 0169-5002, 7 p.Article

Strategies for improving outcomes in NSCLC: A look to the futureSTAHEL, Rolf; PETERS, Solange; PAZ-ARES, Luis et al.Lung cancer. 2013, Vol 82, Num 3, pp 375-382, issn 0169-5002, 8 p.Article

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancerCAPPUZZO, Federico; HIRSCH, Fred R; LUDOVINI, Vienna et al.Journal of the National Cancer Institute. 2005, Vol 97, Num 9, pp 643-655, issn 0027-8874, 13 p.Article